A comprehensive analysis of vasculogenic mimicry related genes to predict the survival rate of HCC and its influence on the tumor microenvironmentdoi:10.3389/fgene.2024.1437715MOLECULAR pathologyVASCULOGENIC mimicryCANCER prognosisTUMOR microenvironment
Multivariate analysis revealed that ADAM8 expression level was an independent prognostic parameter for the overall survival rate of HCC patients. Conclusions: ... Y Zhang,TZ Zha,BS Hu,... - 《Surgeon Journal of the Royal Colleges of Surgeons of Edinburgh & Ireland》 被引量: 4发表: 2012年 ...
Overall survival rate of HCC patients according to treatment types after PSM As shown in Fig.2, there was a gender-based difference according to BMI group in HCC patients. To investigate other factors that could affect the gender difference according to BMI, we separately analyzed by HCC treatme...
The actual survival rate of the patients excluding 9 hospital deaths was 65% at 3 years, and 43% at 5 years. Prothrombin time and size of tumor were the decisive factors that affected long-term prognosis. Nineteen patients had intrahepatic recurrence of HCC among 47 patients who were ...
Conclusion Overall, our study showed that our prognostic risk model can be used to assess prognosis of HCC, which may provide a certain basis for the survival rate of patients with HCC.doi:10.1002/hsr2.202Banglun PanKey Laboratory of Laboratory Medicine, Ministry of Education of China, School ...
2024,Journal of Ethnopharmacology TaichengLu, ...XiaominWang 3.3.1Survival time A total of eight SRs analyzed survival time, including six-monthsurvival rate, one-year survival rate, two-year survival rate, and three-year survival rate. There was a statistically significant improvement inHCCpatient...
Linear correlation between nuclear/cytosolic caspase-8 expression and Ki67/apoptosis rate was performed using the Spearman correlation coefficient and the corresponding p-value. Overall survival was defined as the time from the date of tumor staging to either death from any cause or last follow-up....
January 17, 2021 - The combination of atezolizumab and bevacizumab continued to display improved survival compared with sorafenib in previously untreated patients with advanced hepatocellular carcinoma.
HCC,positive HbsAg,over highed AFP and GT are the dangerous factors effecting the mortality rate of HCC patients(HR(Harzard Ratio)1,P0.05).But there are no significant differences of the mortality rates between the two groups(P=0.202).After matching,the one-year survival rate of RFA and SR...
The response rate for underweight patients receiving the combination therapy was between 5% and 10% compared with underweight patients receiving lenvatinib, which was over 30%. Overall, regardless of weight, patients included in the analysis receiving lenvatinib showed a higher response rate of 30% or...